-
Something wrong with this record ?
Neurogenesis as a Tool for Spinal Cord Injury
K. Havelikova, B. Smejkalova, P. Jendelova
Language English Country Switzerland
Document type Journal Article, Review
Grant support
CZ.02.1.01/0.0./0.0/15_003/0000419
Ministry of Education, Youth and Sports Czech Republic
NLK
Free Medical Journals
from 2000
Freely Accessible Science Journals
from 2000
PubMed Central
from 2007
Europe PubMed Central
from 2007
ProQuest Central
from 2000-03-01
Open Access Digital Library
from 2000-01-01
Open Access Digital Library
from 2007-01-01
Health & Medicine (ProQuest)
from 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
from 2000
PubMed
35409088
DOI
10.3390/ijms23073728
Knihovny.cz E-resources
- MeSH
- Cell Differentiation MeSH
- Humans MeSH
- Spinal Cord MeSH
- Neural Stem Cells * MeSH
- Neurogenesis MeSH
- Neurons MeSH
- Spinal Cord Injuries * therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Spinal cord injury is a devastating medical condition with no effective treatment. One approach to SCI treatment may be provided by stem cells (SCs). Studies have mainly focused on the transplantation of exogenous SCs, but the induction of endogenous SCs has also been considered as an alternative. While the differentiation potential of neural stem cells in the brain neurogenic regions has been known for decades, there are ongoing debates regarding the multipotent differentiation potential of the ependymal cells of the central canal in the spinal cord (SCECs). Following spinal cord insult, SCECs start to proliferate and differentiate mostly into astrocytes and partly into oligodendrocytes, but not into neurons. However, there are several approaches concerning how to increase neurogenesis in the injured spinal cord, which are discussed in this review. The potential treatment approaches include drug administration, the reduction of neuroinflammation, neuromodulation with physical factors and in vivo reprogramming.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019114
- 003
- CZ-PrNML
- 005
- 20220804135351.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms23073728 $2 doi
- 035 __
- $a (PubMed)35409088
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Havelikova, Katerina $u Institute of Experimental Medicine, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic $u Department of Neuroscience, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic
- 245 10
- $a Neurogenesis as a Tool for Spinal Cord Injury / $c K. Havelikova, B. Smejkalova, P. Jendelova
- 520 9_
- $a Spinal cord injury is a devastating medical condition with no effective treatment. One approach to SCI treatment may be provided by stem cells (SCs). Studies have mainly focused on the transplantation of exogenous SCs, but the induction of endogenous SCs has also been considered as an alternative. While the differentiation potential of neural stem cells in the brain neurogenic regions has been known for decades, there are ongoing debates regarding the multipotent differentiation potential of the ependymal cells of the central canal in the spinal cord (SCECs). Following spinal cord insult, SCECs start to proliferate and differentiate mostly into astrocytes and partly into oligodendrocytes, but not into neurons. However, there are several approaches concerning how to increase neurogenesis in the injured spinal cord, which are discussed in this review. The potential treatment approaches include drug administration, the reduction of neuroinflammation, neuromodulation with physical factors and in vivo reprogramming.
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nervové kmenové buňky $7 D058953
- 650 _2
- $a neurogeneze $7 D055495
- 650 _2
- $a neurony $7 D009474
- 650 _2
- $a mícha $7 D013116
- 650 12
- $a poranění míchy $x terapie $7 D013119
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Smejkalova, Barbora $u Institute of Experimental Medicine, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic $u Department of Neuroscience, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic $1 https://orcid.org/0000000248129458
- 700 1_
- $a Jendelova, Pavla $u Institute of Experimental Medicine, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic $u Department of Neuroscience, Second Faculty of Medicine, Charles University, 15006 Prague, Czech Republic $1 https://orcid.org/0000000246449212 $7 xx0068971
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 7 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35409088 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135344 $b ABA008
- 999 __
- $a ok $b bmc $g 1822636 $s 1170357
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 23 $c 7 $e 20220328 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a CZ.02.1.01/0.0./0.0/15_003/0000419 $p Ministry of Education, Youth and Sports Czech Republic
- LZP __
- $a Pubmed-20220720